Introducing the AB Decontamination device. Free from...

On October 14 the U.S. Food and Drug Administration approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies, as the first FDA-approved treatment for Zaire ebolavirus (Ebola virus) infection in adult and pediatric

From Khronika Turkmenistana Website 14 Sep 2020

President [of Turkmenistan] Gurbanguly Berdimuhamedov visited the construction site of a sanatorium in Ak Bugday District's Bagabat village on 13 September. The construction of the sanatorium for 200 beds became known in autumn

A second case of a novel orthopox, first detailed in 2015, has been reported in the the Fairbanks area of Alaska. 

Named Alaskapox, due to it's region of discovery, this orthopox is not yet known to cause sever malady and both of those suffering from the infection reported cases of

DQE, partnering with BlueWillow Biologics, is now the healthcare and public safety distributor of the patented NanoBio Protect nasal antiseptic solution.

Healthcare and public safety workers are in constant contact withunknown pathogens out in our community, including COVID-19. Actions

Dante Labsannounced today a new coronavirus test for current infection based on saliva samples. The test uses real-time SARS-COV2 PCR CE-IVD technology and kits to detect current coronavirus infection from COVID-19,

In December 2019 reports emerged that a Utah woman had been arrested for possesion of a biological weapon. Janie Lynn Ridd, 50, was arrested whilst the case was being investigated by both federal and state authorities. 

According to the affidavit at the time “Through

Elusys Therapeutics, Inc. (Elusys) have announced that Health Canada has approved the company's New Drug

As part of the national response to COVID-19, the Department of Defense (DOD), in coordination with the Department of Health & Human Services (HHS), signed an agreement with BioFire Defense, LLC, a subsidiary of bioMérieux, to expand the production of the BioFire COVID-19 Test for the DOD.

Sanofi and GSK have recently been awarded two large contracts by both the US and EU.

Under Operation Warp Speed in the USA, Sanofi and GSK have been selected to supply 100 million doses of COVID-19 Vaccine.
The vaccine candidate, developed by Sanofi in partnership

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human

BioFactura, Inc. today announced a  Small Business Innovation Research (SBIR) Phase II contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense (DoD). The goal of this project is to develop,

MIT News Office

The prototype mask, which includes an N95 filter, can be easily sterilized and worn many times.

Researchers at MIT and Brigham and Women’s Hospital have designed a new face mask that they believe could stop viral particles as effectively as N95 masks. Unlike N95

The Defense Logistics Agency (DLA) recently awarded Federal Resources a multi-million dollar contract to provide over 4.5 billion gloves to America’s national strategic stockpile. Federal Resources Supply Company was selected by the DLA to continue delivering life-saving Personal Protective

By BBC Monitoring

A Russian Health Ministry official and research centres testing an experimental vaccine against Covid-19 have denied reports that the country's business and political leadership have been given early access to it outside of clinical trials. 

From University of Massachusetts Amherst

Certain methods of decontaminating medical face masks for repeated use during the COVID-19 pandemic appear to damage the masks' integrity and protective function, according to research by a University of Massachusetts Amherst environmental health

A unique type of blood testing equipment manufactured by a small company in West Wales is emerging as an important tool for understanding how Covid-19 affects the body and for choosing the best treatments for patients.

...

GSK and Medicago have announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic adjuvant system. CoVLPs mimic the structure of the virus responsible for COVID-19 disease, allowing

FLIR Systems, Inc. has announced modified thermal cameras for fast and safe noncontact elevated skin temperature* screening. The FLIR EST thermal screening solutions provide frontline screening at building entries and in high traffic areas to improve safety and help curb the spread of COVID-19.

Smiths Detection today announces that it has entered into an agreement to acquire PathSensors, a leading bio-technology solutions and environmental-testing company based in Baltimore, MD. The acquisition expands Smiths Detection’s sensing capabilities across the CBRNE (chemical, biological,

PathogenDx, Inc., an Arizona based

Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), announced today it has been awarded a contract to advance development of a cocktail of anti-botulinum neurotoxin monoclonal antibodies (mAb) by the Department of Defense (DOD) through the Joint

 INOVIO today announced it has received $71 million funding from the U.S. Department of Defense (DoD) to support the large-scale manufacture of the company's proprietary CELLECTRA^® 3PSP smart device and the procurement of CELLECTRA^® 2000 devices, which are

A household appliance, which may be sitting inside your kitchen cabinet, can now be used as a powerful tool in the fight to control COVID-19. Researchers with the Department of Homeland Security (DHS) ...

From army.mil

 A chemical and biological decontamination solution improved through testing and evaluation by the Combat Capabilities Development Command (CCDC) Chemical Biological Center has been identified by the Defense Threat Reduction Agency (DTRA) as an effective COVID-19

Due to the coronavirus pandemic, demand for protective face masks has sky-rocketed in recent months, as wearing masks is now a requirement along with social distancing and hygiene measures. A wide range of masks is available, with the leading model being the N95. The authorities insist on the

Bavarian Nordic announced today this month that the Company has entered into a new supply contract with Janssen Vaccines & Prevention B.V., part of the Janssen Pharmaceutical Companies of Johnson & Johnson valued at USD 13.9 million. 

Under the contract, Bavarian Nordic

The Department of Homeland Security Science and Technology Directorate (S&T) added an online calculator last week that estimates the natural decay of SARS-CoV-2 in the air.

The calculator is based on research still underway at S&T’s National Biodefense Analysis and

It was announced on June 15th that the US Food and Drug Adminsitration (FDA) had revoked the Emergency Use Autorisation of oral formulations of chloroquine phosphate and hydroxychloroquine sulfate for the treatment of COVID-19. 

A request was submitted to the FDA by BARDA

SIGA Technologies, Inc. (SIGA) today announced that the United States Department of Defense (DoD), via the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological,

In a new study published this week in The Lancet, NIAID scientists describe the results of a small Phase 1 trial of a vaccine designed to provide broad protection against mosquito-borne diseases. The trial indicated that the vaccine is safe and induces a strong immune

The Director General of the International Atomic Energy Agency (IAEA), Rafael Mariano Grossi, launched an initiative today to strengthen global preparedness for future pandemics like COVID-19. The project, called ZODIAC, builds on the IAEA’s experience in assisting countries in the use of

The House of Lords Science and Technology Committee will next week continue its inquiry into the science of COVID-19.

The committee will hear from further leading academics and medical professionals on the immune response to the virus, before continuing with a more detailed look at the

Emergent BioSolutions Inc. announced on June 11th it will deploy its molecule-to-market contract development and manufacturing (CDMO) services to support the manufacturing of AstraZeneca’s vaccine candidate for COVID-19, AZD1222, a viral vector-based, weakened version of adenovirus containing

The current pandemic of Covid-19 has shown the vulnerability of our healthcare systems when faced with viral infections without a known treatment Understanding the transmission behavior of SARS-CoV-2 in the air will be a crucial step to managing the current outbreak and design the appropriate

On the same day that the 42 day countdown to the end of the Ebola epidemic was started in the Deomcratic Republic of Congo another outbreak began in Equateur Province. 

Blauer Manufacturing announced on June 11th that it received formal 3^rd party certification for its new BIO-99™ coverall to the NFPA 1999 Standard on Protective Clothing and Ensembles for Emergency Medical Operations for multiple-use (...

The Tiki Respiratory Protection Mask

Tiki was developed in Sweden, intended for use in demanding settings with the highest requirements of protection against airborne particles and bacteria. The Tiki mask is reusable, has self-adjusting ventilation and is operated with batteries. The

In a follow up to the story posted on May 4th, Government officials in the Czech Republic have expelled two Russian diplomats over a hoax poison plot against local politicians.

SIGA Technologies, Inc. today announced its first international delivery of TPOXX (tecovirimat), with 2,500 courses delivered to the Canadian Department of National Defence (CDND).  On April 3, 2020, the Company previously announced that the CDND is expected to purchase up

Two Lawrence Livermore National Laboratory (LLNL) researchers who have worked for more than eight years to develop a tularemia vaccine are part of a three-institution team that has been funded to bring their candidate

GSK today confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted COVID-19 vaccine candidates.

GSK today confirmed its intention to manufacture 1 billion doses of its pandemic vaccine

Follow-up summaries of oral evidence sessions are being produced by the House of Lords Science and Technology Committee in a move aimed at providing the public with up-to-date information on the science of COVID-19.

The first summary has been published today, with notes on last week’s

A new coalition of more than 500 scientists from around the world has been created to share data on COVID-19 gleaned from the use of mass spectrometry techniques which examine people’s blood and other biomarkers.

Announced in ...

Through innovation, hard work and a $200,000 grant from the National Science Foundation, a research team led by chemistry Prof. Omar Farha will work to develop a reusable, virus-deactivating face mask for healthcare workers on the frontlines of the COVID-19 pandemic.

According to a May

After reaching a landmark agreement with the University of Oxford today for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2, AstraZeneca have now committed to at least 400 million

DetectaChem, the world leader in innovative portable detection technologies, is preparing to launch a ground-breaking new COVID-19 (Coronavirus) testing solution utilizing automated smartphone detection and reporting. This solution enables actionable infection result data reports anytime,

Kromek, a worldwide supplier of detection technology focusing on the medical, security screening and nuclear markets, is pleased to announce that it has been awarded an extension to its contract by the Defense Advanced Research Projects Agency (“DARPA”), an agency of the US Department of

The isolation pod known as the EpiShuttle has finally reached France for evaluation from professional caretakers and medical transport. France is still comping with a large amount of corona patients and high rates of critical cases.

The EpiShuttle is already in service with The

Zeteo Biomedical LLC, Inc., a privately held, medical device company, in collaboration with the Nanovaccine Institute at Iowa State University, has been awarded a five year NIH grant to develop a room temperature stable, universal nasal flu vaccine. Zeteo will provide nasal delivery device